Growth Metrics

Biomerica (BMRA) Other Non Operating Income (2010 - 2026)

Biomerica recorded quarterly Other Non Operating Income of -$6000.0 in Q1 2026, up 90.77% quarter-over-quarter from -$65000.0 in Q2 2025, and down 113.95% year-over-year from $43000.0 in Q1 2025.

Biomerica's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$6000.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 113.95% year-over-year to -$6000.0; the TTM figure through Feb 2026 stood at -$29507.0 (down 159.37% YoY), while the FY2025 annual figure was $75000.0, up 150.68% from the prior year.
  • Other Non Operating Income came in at -$6000.0 for Q1 2026 at Biomerica, up from -$65000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $43000.0 in Q1 2025 to a low of -$65000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Biomerica 7.12 Mn 5.78 Mn -44,000.00

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 -6,000.00
May 31, 2025 -65,000.00
Feb 28, 2025 43,000.00
May 31, 2013 -1,507.00
Feb 28, 2013 7,079.00
Nov 30, 2012 1,127.00
Aug 31, 2012 808.00
May 31, 2012 27,265.00
Feb 29, 2012 72,526.00
Nov 30, 2011 1,006.00
Aug 31, 2011 891.00
May 31, 2011 113,523.00
Feb 28, 2011 388.00
Nov 30, 2010 177,752.00